Literature DB >> 27376452

Dexamethasone palmitate for patients with engraftment syndrome is associated with favorable outcome for children with hematological malignancy.

H Sakaguchi1, K Matsumoto2, N Yoshida1, K Narita1, M Hamada1, S Kataoka1, N Miyagawa1, T Yoshikawa3, M Ito4, K Kato1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27376452     DOI： 10.1038/bmt.2016.178

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  14 in total

Review 1.  Engraftment syndrome following hematopoietic stem cell transplantation.

Authors:  T R Spitzer
Journal:  Bone Marrow Transplant       Date:  2001-05       Impact factor: 5.483

2.  Clinical significance of hemophagocytosis in BM clot sections during the peri-engraftment period following allogeneic hematopoietic SCT.

Authors:  N Imahashi; Y Inamoto; M Ito; D Koyama; T Goto; K Onodera; A Seto; K Watanabe; M Imahashi; S Nishiwaki; S Tsukamoto; T Yasuda; Y Ozawa; K Miyamura
Journal:  Bone Marrow Transplant       Date:  2011-04-18       Impact factor: 5.483

3.  Hemophagocytic syndrome: a rare complication of allogeneic nonmyeloablative hematopoietic stem cell transplantation.

Authors:  Y Abe; I Choi; K Hara; T Matsushima; J Nishimura; S Inaba; H Nawata; K Muta
Journal:  Bone Marrow Transplant       Date:  2002-05       Impact factor: 5.483

4.  Engraftment syndrome after nonmyeloablative allogeneic hematopoietic stem cell transplantation: incidence and effects on survival.

Authors:  Edward Gorak; Nancy Geller; Ramaprasad Srinivasan; Igor Espinoza-Delgado; Teresa Donohue; A John Barrett; Anthony Suffredini; Richard Childs
Journal:  Biol Blood Marrow Transplant       Date:  2005-07       Impact factor: 5.742

5.  Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantation.

Authors:  F Baron; M Labopin; D Niederwieser; S Vigouroux; J J Cornelissen; C Malm; L L Vindelov; D Blaise; J J W M Janssen; E Petersen; G Socié; A Nagler; V Rocha; M Mohty
Journal:  Leukemia       Date:  2012-05-22       Impact factor: 11.528

6.  Incidence, predisposing factors, and outcome of engraftment syndrome in pediatric allogeneic stem cell transplant recipients.

Authors:  Irene Schmid; Daniel Stachel; Philipp Pagel; Michael H Albert
Journal:  Biol Blood Marrow Transplant       Date:  2008-04       Impact factor: 5.742

7.  Peri-engraftment syndrome in allogeneic hematopoietic SCT.

Authors:  K T Hong; H J Kang; N H Kim; M S Kim; J W Lee; H Kim; K D Park; H Y Shin; H S Ahn
Journal:  Bone Marrow Transplant       Date:  2012-09-24       Impact factor: 5.483

8.  Engraftment syndrome after allogeneic hematopoietic cell transplantation predicts poor outcomes.

Authors:  Lawrence Chang; David Frame; Thomas Braun; Erin Gatza; David A Hanauer; Shuang Zhao; John M Magenau; Kathryn Schultz; Hemasri Tokala; James L M Ferrara; John E Levine; Pavan Reddy; Sophie Paczesny; Sung Won Choi
Journal:  Biol Blood Marrow Transplant       Date:  2014-06-02       Impact factor: 5.742

9.  Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia.

Authors:  K M Sullivan; P L Weiden; R Storb; R P Witherspoon; A Fefer; L Fisher; C D Buckner; C Anasetti; F R Appelbaum; C Badger
Journal:  Blood       Date:  1989-05-01       Impact factor: 22.113

10.  Dexamethasone palmitate ameliorates macrophages-rich graft-versus-host disease by inhibiting macrophage functions.

Authors:  Satoshi Nishiwaki; Takayuki Nakayama; Makoto Murata; Tetsuya Nishida; Seitaro Terakura; Shigeki Saito; Tomonori Kato; Hiroki Mizuno; Nobuhiko Imahashi; Aika Seto; Yukiyasu Ozawa; Koichi Miyamura; Masafumi Ito; Kyosuke Takeshita; Hidefumi Kato; Shinya Toyokuni; Keisuke Nagao; Ryuzo Ueda; Tomoki Naoe
Journal:  PLoS One       Date:  2014-05-07       Impact factor: 3.240
View more
  1 in total

1.  Macrophage elimination in bone marrow by dexamethasone palmitate is associated with successful engraftment in patients with hemophagocytic syndrome.

Authors:  Hiroyuki Sugiura; Ken-Ichi Matsuoka; Masayuki Matsuda; Shuntaro Ikegawa; Tomoko Inomata; Taiga Kuroi; Takeru Asano; Shohei Yoshida; Hisakazu Nishimori; Keiko Fujii; Nobuharu Fujii; Yoshinobu Maeda
Journal:  Int J Hematol       Date:  2019-05-16       Impact factor: 2.490
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.